Clinical Trials Sponsored by Rogier Caluwe

Total 727 results

University of Michigan Rogel Cancer Center

Terminated

Testing the Effect of Mindfulness for Prostatectomy Outcomes (TEMPO)

Prostate Cancer

United States
University of Michigan Rogel Cancer Center

Completed

VISmodegib for ORbital and Periocular Basal Cell Carcinoma (VISORB)

Carcinoma, Basal Cell

United States
University of Michigan Rogel Cancer Center

Completed

Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
University of Michigan Rogel Cancer Center

Terminated

Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery

Metastatic Melanoma | Brain Metastases

United States
University of Michigan Rogel Cancer Center

Completed

A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma

Glioma

United States
University of Michigan Rogel Cancer Center

Completed

A Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome

Hemophagocytic Syndrome (HPS)

United States
University of Michigan Rogel Cancer Center

Terminated

Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders

Lymphoproliferative Disorders | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Lymphoma, T-Cell, Cutaneous | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Lymphoma, T-Cell, Peripheral

United States
University of Michigan Rogel Cancer Center

Completed

Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas

Adenocarcinoma of the Pancreas

United States
University of Michigan Rogel Cancer Center

Completed

A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients

Pancreatic Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Pilot Study of Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Completed

MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy

Brain Metastases

United States
University of Michigan Rogel Cancer Center

Withdrawn

Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular Carcinoma

Carcinoma, Hepatocellular

United States
University of Michigan Rogel Cancer Center

Completed

Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Phase I/II Calcitriol in Lung Cancer

Non Small Cell Lung Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma

Renal Cell Carcinoma

United States
University of Michigan Rogel Cancer Center

Completed

A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Withdrawn

Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Chronic Lymphocytic Leukemia | Lymphoma, Small Lymphocytic

United States
University of Michigan Rogel Cancer Center

Completed

Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer

Metastatic Breast Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma (RVDD)

Multiple Myeloma

United States, Canada
University of Michigan Rogel Cancer Center

Completed

A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer

Liver Cancer | Hepatocellular Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant

Multiple Myeloma | Lymphoma, Low-Grade | Lymphocytic Leukemia, Chronic

United States
University of Michigan Rogel Cancer Center

Terminated

A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Therapy in Children With Primary Brain Tumors

Brain Tumor, Primary

United States
University of Michigan Rogel Cancer Center

Terminated

Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.

Prostate Cancer | Bladder Cancer | Urothelial Carcinoma | Non-Small-Cell Lung Carcinoma

United States
University of Michigan Rogel Cancer Center

Completed

A Study Using Cone Beam CT for Head and Neck Cancer

Head and Neck Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer (LOGRIBMET)

Obesity | Breast Cancer | Arthralgia

United States
University of Michigan Rogel Cancer Center

Completed

The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease

Acute Graft Versus Host Disease

United States
University of Michigan Rogel Cancer Center

Terminated

A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic Carcinoma

Metastatic Pancreatic Carcinoma

United States
University of Michigan Rogel Cancer Center

Completed

Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma

Sarcoma, Soft Tissue

United States
University of Michigan Rogel Cancer Center

Completed

A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma (OCR)

Osteosarcoma

United States
University of Michigan Rogel Cancer Center

Completed

Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer

Colorectal Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Tetrathiomolybdate in Hormone Refractory Prostate Cancer

Prostate Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder

Bladder Cancer

United States
University of Michigan Rogel Cancer Center

Withdrawn

A Randomized Comparative Study of a Weekly Versus Every Other Week Nurse Practitioner-led Symptom Management Clinic for Head and Neck Cancer Patients Undergoing Concurrent Chemotherapy and Radiation

Head and Neck Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Cross-Sectional Study of Oral Health in Patients After Parotid-Sparing Radiation Therapy for Head and Neck Cancer

Head and Neck Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma

Thyroid Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Completed

The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease

Graft-Versus-Host Disease

United States
University of Michigan Rogel Cancer Center

Completed

Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma

Colorectal Carcinoma

United States
University of Michigan Rogel Cancer Center

Completed

Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma

Multiple Myeloma

United States
University of Michigan Rogel Cancer Center

Terminated

Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling

Advanced Non-Small Cell Lung Cancer

United States
University of Michigan Rogel Cancer Center

Recruiting

Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer (ARTHOUSE)

Oropharynx Cancer | HPV-Related Carcinoma

United States
University of Michigan Rogel Cancer Center

Not yet recruiting

Breast Cancer Resiliency Through Exercise Program (B-REP) (B-REP)

Breast Cancer Female

United States
University of Michigan Rogel Cancer Center

Not yet recruiting

Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing Surgery

Head and Neck Cancer
University of Michigan Rogel Cancer Center

Not yet recruiting

Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors

Anxiety

United States
University of Michigan Rogel Cancer Center

Recruiting

A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

Hepatocellular Carcinoma

United States
University of Michigan Rogel Cancer Center

Recruiting

Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Recruiting

Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)

Metastatic Melanoma | Liver Metastases | Melanoma, Mucosal | Melanoma, Ocular | Melanoma, Cutaneous

United States
University of Michigan Rogel Cancer Center

Recruiting

Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])

Prostate Cancer

United States

Clinical Trials Sponsored by Rogier Caluwe

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations